Top compounds associated with response to SNAI3


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 8e-07
mRNA MI-2 CTRPv2 pan-cancer AAC 0.28 8e-07
mRNA cabozantinib CTRPv2 pan-cancer AAC 0.19 2e-06
mRNA BIRB 0796 CTRPv2 pan-cancer AAC 0.2 2e-06
mRNA OSI-930 GDSC1000 pan-cancer AAC 0.16 2e-06
mRNA Sunitinib CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA AMG-706 GDSC1000 pan-cancer AAC 0.16 4e-06
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 8e-06
mRNA MK-2206 CTRPv2 pan-cancer AAC 0.17 1e-05
mRNA XL-184 GDSC1000 pan-cancer AAC 0.14 2e-05
Download CSV